ATS 2018 International Conference - Mobile

Evaluating the Impact and Benefits of Once Daily Fluticasone Furoate/Vilanterol (FF/VI) in Asthma and Chronic Obstructive Pulmonary Disease (COPD) [Board No. P18]

Location: Board no. P18

Session Type: Thematic Poster Session

Tuesday

May

22

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Jake Macey

MSc
ICON plc

Magdalena Vanya

PhD
ICON PLC

Gail Miles

MSc
NHS

Helen Doll

DPhil
ICON plc

Henrik Svedsater

PhD
GSK

Lisa Bradshaw

PhD
NHS, Sheffield & Health and Safety Laboratory

View Abstract

Evaluating the Impact and Benefits of Once Daily Fluticasone Furoate/Vilanterol (FF/VI) in Asthma and Chronic Obstructive Pulmonary Disease (COPD)

Parent Sessions

C37 - OPTIMIZING ASTHMA CARE ACROSS DIVERSE PATIENTS...
05-22-2018 9:15 AM - 4:15 PM